₹ 1,454.90
-19.50 (-1.32%)
A
Alivus Life Sciences
₹ 1,454.90
Alivus Life Sciences Fundamentals
Company Valuation
Market Cap (₹ Cr.)
17,862
PE Ratio
27.10
PB Ratio
5.00
Dividend Yield
0.34%
ROE
16.94%
ROCE
21.78%
Book Value (₹)
295.31
Face Value (₹)
2.00
Analyse ALIVUS with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 74.91% | 74.91% | 74.87% | 74.87% | 74.85% |
| Domestic Institutional Investors (DII) | 5.47% | 7.12% | 7.28% | 7.18% | 7.03% |
| Foreign Institutional Investors (FII) | 6.84% | 5.09% | 5.29% | 5.54% | 5.93% |
| Public Investors | 10.14% | 10.21% | 9.87% | 10.05% | 10.11% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
ALIVUS Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Smallcap
BSE Scrip Code
543322
NSE Scrip Name
ALIVUS
ISIN
INE03Q201024

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






